Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 6535
Gene Symbol: SLC6A8
SLC6A8
Squamous cell carcinoma of esophagus
0.060 Biomarker BEFREE No survival benefits had been observed while comparing IMRT versus 3D-CRT in CESCC patients. 31048664

2020

Entrez Id: 6535
Gene Symbol: SLC6A8
SLC6A8
Squamous cell carcinoma of esophagus
0.060 Biomarker BEFREE A total of 5832 patients with clinical stage II and III oesophageal SCC receiving CRT-S (1754) or dCRT (4078) were included. 30395362

2019

Entrez Id: 6535
Gene Symbol: SLC6A8
SLC6A8
Squamous cell carcinoma of esophagus
0.060 GeneticVariation BEFREE The SLNM should be dealt with as a regional rather than a distant disease in patients with ESCC when treated with CRT. 30922343

2019

Entrez Id: 6535
Gene Symbol: SLC6A8
SLC6A8
Squamous cell carcinoma of esophagus
0.060 Biomarker BEFREE We retrospectively compared clinical outcomes between ER-CRT and D-CRT in patients diagnosed with ESCC with SM invasion between 2003 and 2014. 29477349

2018

Entrez Id: 6535
Gene Symbol: SLC6A8
SLC6A8
Squamous cell carcinoma of esophagus
0.060 Biomarker BEFREE Data of 1647 patients with clinical stage II/III esophageal squamous cell carcinoma (ESCC), including 1245 receiving preoperative chemoradiation followed by esophagectomy (pre-OP CRT group) and 402 receiving primary esophagectomy followed postoperative chemoradiation (post-OP CRT group), were obtained from a nationwide database. 28457536

2017

Entrez Id: 6535
Gene Symbol: SLC6A8
SLC6A8
Squamous cell carcinoma of esophagus
0.060 Biomarker BEFREE The expression levels of three genes determined by qPCR provide a possible model for ESCC CRT prediction, which will facilitate the individualization of ESCC treatment. 24907633

2014